Evidence from mouse models of AD have demonstrated that treatment with iododiflunisal, a TTR stabilizer that crosses the BBB, decreases the rate of Aβ deposition in the brain and may improve cognitive function [109,110]. This evidence concerns the gene TTR and Alzheimer disease.